Erudio Healtherudio.com
Clinical trial · no report yet · Phase 1
NCT06150157 trial: what clinicians have said so far
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- NCT06150157 ↗
- Recruiting
- Janssen Research & Development, LLC
- Focused size, estimated: 1–150 verified statements once built
We haven't built an HCP commentary report on NCT06150157 yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NCT06150157 so far
Podcasts, YouTube videos and posts on X and Bluesky we have indexed that name the trial. LinkedIn posts are read for reports and the Enterprise MCP, not yet for this index. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 2 posts on X, typically up to 9 once built | |
| 1 post on Bluesky, typically up to 4 once built |
The trial
ClinicalTrials.gov- Official title
- A First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ 88549968, a T-cell Redirecting Bispecific Antibody for CALR-mutated Myeloproliferative Neoplasms
- Phase
- Phase 1
- Status
- Recruiting
- Conditions
- Neoplasms
- Interventions
- JNJ-88549968; Ruxolitinib; Momelotinib
- Arms
- Dose Escalation (Part 1), Dose Expansion (Part 2) and Part 1b (US only), Part 2b (US only) · Experimental
- Enrollment
- 300 (estimated)
- Primary outcomes
- Part 1, Part 1b (US Only): Number of Participants With Dose Limiting Toxicity (DLT)
- Part 1, 2, Part 1b (US Only), Part 2b (US Only): Number of Participants with Adverse Events (AEs)
- Part 1, 2, Part 1b (US Only), Part 2b (US Only): Number of Participants with Adverse Events (AEs) by Severity
- Sponsor
- Janssen Research & Development, LLC
- Start
- Dec 20, 2023
- Primary completion
- Jun 14, 2027 (estimated)
- Results posted
- No
- Registry record
- NCT06150157 · updated Nov 4, 2026